middle.news
Starpharma Secures $3.7M Boost from R&D Tax Incentive for 2025
2:27am on Saturday 30th of August, 2025 AEST
•
Biotechnology
Read Story
Starpharma Secures $3.7M Boost from R&D Tax Incentive for 2025
2:27am on Saturday 30th of August, 2025 AEST
Key Points
Received $3.7 million R&D Tax Incentive refund for FY2025
Supports ongoing investment in dendrimer technology development
Funds part of Australian Federal Government’s innovation support program
Starpharma focuses on commercialising clinical-stage dendrimer products
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SPL
OPEN ARTICLE